Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Indications for Warfarin Therapy”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)UnknownNCT00691470
What this trial is testing

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

Who this might be right for
Atrial FibrillationAtrial FlutterVenous Thromboembolic Disease+2 more
ARYx Therapeutics 600
Large-scale testing (Phase 3)Study completedNCT00291330
What this trial is testing

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,564
Large-scale testing (Phase 3)UnknownNCT00700895
What this trial is testing

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Who this might be right for
Indications for Warfarin Therapy
National University Hospital, Singapore 320
Large-scale testing (Phase 3)Study completedNCT00680186
What this trial is testing

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,589

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation